Consolidated statement of financial position
In thousands of euro (before profit appropriation)
|
Note
|
31 December 2017
|
31 December 2016
|
Assets
|
Property, plant and equipment
|
17
|
205,904
|
194,749
|
Intangible assets and goodwill
|
18
|
96,229
|
102,181
|
Investment property
|
19
|
830
|
830
|
Trade and other receivables
|
21
|
9,298
|
10,952
|
Equity-accounted investees
|
20
|
24,018
|
21,653
|
Deferred tax assets
|
16
|
2,998
|
3,230
|
Non-current assets
|
|
339,277
|
333,595
|
|
Inventories
|
22
|
72,010
|
70,024
|
Biological assets
|
23
|
4,714
|
5,117
|
Trade and other receivables
|
21
|
208,170
|
213,736
|
Current tax assets
|
|
86
|
943
|
Cash and cash equivalents
|
24
|
161,297
|
152,854
|
Assets held for sale
|
25
|
1,737
|
-
|
Current assets
|
|
448,014
|
442,674
|
|
Total assets
|
|
787,291
|
776,269
|
|
Equity
|
Share capital
|
|
1,063
|
1,063
|
Share premium
|
|
143,554
|
143,554
|
Treasury share reserve
|
|
-55
|
-1
|
Translation reserve
|
|
-5,692
|
-3,609
|
Hedging reserve
|
|
-
|
27
|
Other reserves and retained earnings
|
|
207,878
|
229,816
|
Unappropriated result
|
|
58,554
|
53,260
|
Equity attributable to shareholders of the Company
|
26
|
405,302
|
424,110
|
Non-controlling interests
|
33
|
4,629
|
4,880
|
|
Total equity
|
|
409,931
|
428,990
|
|
Liabilities
|
Loans and borrowings
|
28
|
44,508
|
45,652
|
Employee benefits
|
15
|
46,910
|
65,328
|
Provisions
|
29
|
2,249
|
3,295
|
Trade and other payables
|
30
|
8,255
|
7,660
|
Deferred tax liabilities
|
16
|
9,939
|
9,875
|
Non-current liabilities
|
|
111,861
|
131,810
|
|
Bank overdrafts
|
24
|
49,690
|
45,535
|
Loans and borrowings
|
28
|
28
|
126
|
Provisions
|
29
|
1,132
|
2,050
|
Trade and other payables
|
30
|
206,982
|
161,326
|
Current tax liability
|
|
7,667
|
6,432
|
Current liabilities
|
|
265,499
|
215,469
|
|
Total liabilities
|
|
377,360
|
347,279
|
|
Total equity and liabilities
|
|
787,291
|
776,269
|
The notes 1 to 51 are an integral part of these consolidated financial statements.